BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12782762)

  • 1. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
    Siegler G; Kremmer E; Gonnella R; Niedobitek G
    Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
    Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
    Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
    PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
    Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
    J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
    Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
    J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
    Fries KL; Miller WE; Raab-Traub N
    Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.
    Siegler G; Meyer B; Dawson C; Brachtel E; Lennerz J; Koch C; Kremmer E; Niedobitek E; Gonnella R; Pilch BZ; Young LS; Niedobitek G
    Int J Cancer; 2004 Nov; 112(2):265-72. PubMed ID: 15352039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells.
    Dürkop H; Foss HD; Demel G; Klotzbach H; Hahn C; Stein H
    Blood; 1999 Jan; 93(2):617-23. PubMed ID: 9885224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease.
    Murray PG; Flavell JR; Baumforth KR; Toomey SM; Lowe D; Crocker J; Ambinder RF; Young LS
    J Pathol; 2001 Jun; 194(2):158-64. PubMed ID: 11400143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
    Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
    Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
    Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
    Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.